Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients

Clinical trial NCT01420146 · COMPLETED

Trial details

NCT number: NCT01420146
Sponsor: Jules Bordet Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms Secondary HER2 Positive Carcinoma of Breast

Start date: 2011-08-01
Primary completion: 2015-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.